Michael Singer, MD, shared insights from on his experience using a preservative-free, chloroprocaine ophthalmic gel as ...

In a presentation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Lu, MD, a retina specialist at Johns Hopkins Medicine, discussed the application of large language ...

The acquisition creates a clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations. Ocuphire Pharma, Inc. has announced the all-stock ...

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr., MD, & Heather Gills Artificial Intelligence ...

A Chinese study 1 (NCT01906814) of the number of cycles of adjuvant chemotherapy for patients with unilateral pathologic high-risk retinoblastoma, found that 3 cycles of carboplatin, etoposide, and ...